{"date":"2026-04-17","count":34,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6677-2026-04-17-1907-156vh1m","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"19:07:24","subject":"公告本公司董事會決議召開115年股東會常會補充公告(新增議案)","clause":"第32款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-04-17 19:07，「公告本公司董事會決議召開115年股東會常會補充公告(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2026-04-17-1903-mrhq3h","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"19:03:20","subject":"更正公告本公司董事會決議115年股東常會召開事宜(更正議案)","clause":"第17款","fact_date":"2026-03-06","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2026-04-17 19:03，「更正公告本公司董事會決議115年股東常會召開事宜(更正議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-04-17-1856-bwopfv","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"18:56:17","subject":"公告本公司董事會決議不分派股利","clause":"第31款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-04-17 18:56，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-17-1820-525fm5","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"18:20:21","subject":"代本公司重要子公司台灣永生公告累積虧損達實收資本額二分之一","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-17 18:20，「代本公司重要子公司台灣永生公告累積虧損達實收資本額二分之一」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4153-2026-04-17-1820-jkyiy2","company_id":"4153","company":"鈺緯","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"18:20:19","subject":"公告本公司民國115年第1季財務報告董事會預計召開日期為民國115年4月27日","clause":"第31款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：鈺緯（4153），2026-04-17 18:20，「公告本公司民國115年第1季財務報告董事會預計召開日期為民國115年4月27日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-17-1820-13gchx0","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"18:20:08","subject":"代本公司重要子公司台灣永生細胞股份有限公司公告115年度股東常會(董事會代行)重要決議事項","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-17 18:20，「代本公司重要子公司台灣永生細胞股份有限公司公告115年度股東常會(董事會代行)重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4178-2026-04-17-1819-133s7hc","company_id":"4178","company":"永笙-KY","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"18:19:53","subject":"本公司董事會決議召開民國115年股東常會(新增討論事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永笙-KY（4178），2026-04-17 18:19，「本公司董事會決議召開民國115年股東常會(新增討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6762-2026-04-17-1747-p61487","company_id":"6762","company":"達亞","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"17:47:06","subject":"115年第一季財務報告董事會預計召開日期為115年04月27日","clause":"第31款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：達亞（6762），2026-04-17 17:47，「115年第一季財務報告董事會預計召開日期為115年04月27日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8279-2026-04-17-1740-mhe9v1","company_id":"8279","company":"生展","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"17:40:59","subject":"公告115年第1季財務報告董事會召開日期","clause":"第31款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：生展（8279），2026-04-17 17:40，「公告115年第1季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-04-17-1724-l4muu2","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:24:57","subject":"公告本公司董事會決議通過新設立中國子公司","clause":"第44款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-04-17 17:24，「公告本公司董事會決議通過新設立中國子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-04-17-1724-1lks7u1","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:24:12","subject":"本公司董事會決議發行115年度限制員工權利新股","clause":"第9款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-04-17 17:24，「本公司董事會決議發行115年度限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-04-17-1720-11wjw0o","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:20:11","subject":"公告本公司董事會決議股利分派","clause":"第31款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-04-17 17:20，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-04-17-1719-1a4htu9","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:19:56","subject":"公告本公司董事會決議召開115年股東常會(新增報告及討論事項)","clause":"第32款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-04-17 17:19，「公告本公司董事會決議召開115年股東常會(新增報告及討論事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-04-17-1719-5ici0y","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:19:38","subject":"本公司董事會決議發行限制員工權利新股案","clause":"第9款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-04-17 17:19，「本公司董事會決議發行限制員工權利新股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-04-17-1719-1b89la1","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:19:17","subject":"公告本公司董事會通過114年度財務報告","clause":"第43款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-04-17 17:19，「公告本公司董事會通過114年度財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6610-2026-04-17-1718-bwopfv","company_id":"6610","company":"安成生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:18:51","subject":"公告本公司董事會決議不分派股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安成生技（6610），2026-04-17 17:18，「公告本公司董事會決議不分派股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-04-17-1705-1eaw5kd","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"17:05:12","subject":"代重要子公司UOC Europe Holding SA公告股東常會董事改選當選名單","clause":"第6款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-04-17 17:05，「代重要子公司UOC Europe Holding SA公告股東常會董事改選當選名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4129-2026-04-17-1704-17n93vj","company_id":"4129","company":"聯合","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"17:04:36","subject":"代重要子公司UOC Europe Holding SA公告股東常會重要決議事項","clause":"第18款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：聯合（4129），2026-04-17 17:04，「代重要子公司UOC Europe Holding SA公告股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6864-2026-04-17-1704-58ae5","company_id":"6864","company":"元樟生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"17:04:13","subject":"公告本公司自主研發之「連接子共軛化合物」(TenTacle)取得經濟部智慧財產局核發發明專利核准審定書。","clause":"第44款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：元樟生技（6864），2026-04-17 17:04，「公告本公司自主研發之「連接子共軛化合物」(TenTacle)取得經濟部智慧財產局核發發明專利核准審定書。」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6666-2026-04-17-1656-1egfkms","company_id":"6666","company":"羅麗芬-KY","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"16:56:22","subject":"公告本公司董事會通過重要決議","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：羅麗芬-KY（6666），2026-04-17 16:56，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-04-17-1655-1z0xz0c","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"16:55:57","subject":"公告本公司依據國際會計準則第36號公報認列資產減損","clause":"第44款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-04-17 16:55，「公告本公司依據國際會計準則第36號公報認列資產減損」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6677-2026-04-17-1652-5j9yh6","company_id":"6677","company":"瑩碩生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"16:52:43","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：瑩碩生技（6677），2026-04-17 16:52，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-04-17-1652-5j9yh6","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"16:52:37","subject":"公告本公司董事會通過114年度合併財務報告","clause":"第43款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-04-17 16:52，「公告本公司董事會通過114年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6850-2026-04-17-1644-8ygsq2","company_id":"6850","company":"光鼎生技","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"16:44:47","subject":"公告本公司董事會決議114年度員工及董事酬勞分派案","clause":"第44款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：光鼎生技（6850），2026-04-17 16:44，「公告本公司董事會決議114年度員工及董事酬勞分派案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4745-2026-04-17-1638-1yjd6yf","company_id":"4745","company":"合富-KY","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"16:38:48","subject":"公告本公司第二次買回庫藏股執行結果（修正實際買回期間，並說明買回數量於執行完畢當日達已發行股份總數4%）","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：合富-KY（4745），2026-04-17 16:38，「公告本公司第二次買回庫藏股執行結果（修正實際買回期間，並說明買回數量於執行完畢當日達已發行股份總數4%）」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2026-04-17-1632-vl81e7","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"16:32:07","subject":"公告本公司115年第1季財務報告董事會召開日期","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2026-04-17 16:32，「公告本公司115年第1季財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-04-17-1601-hcjts7","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"16:01:46","subject":"更正公告本公司董事會決議召開115年股東常會(新增議案)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-04-17 16:01，「更正公告本公司董事會決議召開115年股東常會(新增議案)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-04-17-1559-z86kcb","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"15:59:11","subject":"公告本公司董事會決議擬發行115年限制員工權利新股","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-04-17 15:59，「公告本公司董事會決議擬發行115年限制員工權利新股」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6469-2026-04-17-1558-aufijy","company_id":"6469","company":"大樹","market":"上櫃","industry":"生技醫療","date":"2026-04-17","time":"15:58:47","subject":"公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股及或私募國內無擔保可轉換公司債案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：大樹（6469），2026-04-17 15:58，「公告本公司董事會決議不繼續辦理114年股東常會通過之私募普通股及或私募國內無擔保可轉換公司債案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7729-2026-04-17-1526-1lhzzrd","company_id":"7729","company":"仲恩生醫","market":"興櫃","industry":"生技醫療","date":"2026-04-17","time":"15:26:16","subject":"公告本公司114年第一次現金增資基準日暨相關事宜(補充代收股款及存儲專戶行庫)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：仲恩生醫（7729），2026-04-17 15:26，「公告本公司114年第一次現金增資基準日暨相關事宜(補充代收股款及存儲專戶行庫)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-17-1458-1dgvjpk","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"14:58:17","subject":"公告本公司股票初次上市現金增資股款委託代收及存儲價款機構","clause":"第44款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-17 14:58，「公告本公司股票初次上市現金增資股款委託代收及存儲價款機構」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4195-2026-04-17-1439-l0uvpa","company_id":"4195","company":"基米-創","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"14:39:39","subject":"公告本公司115年第一次股東臨時會重要決議事項","clause":"第15款","fact_date":"2026-04-17","cite_as":"公開資訊觀測站重大訊息：基米-創（4195），2026-04-17 14:39，「公告本公司115年第一次股東臨時會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7803-2026-04-17-1418-hyg6c0","company_id":"7803","company":"雲象科技-創","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"14:18:38","subject":"本公司將於115年4月24日召開創新板上市前業績發表會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：雲象科技-創（7803），2026-04-17 14:18，「本公司將於115年4月24日召開創新板上市前業績發表會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4164-2026-04-17-1053-1fqkmsr","company_id":"4164","company":"承業醫","market":"上市","industry":"生技醫療","date":"2026-04-17","time":"10:53:48","subject":"澄清媒體報導","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：承業醫（4164），2026-04-17 10:53，「澄清媒體報導」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}